MICHAEL FRUMOVITZ to Angiogenesis Inhibitors
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Angiogenesis Inhibitors.
Connection Strength
0.059
-
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol. 2007 Mar; 104(3):768-78.
Score: 0.042
-
Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol. 2014 Jul; 134(1):6-9.
Score: 0.017